Lee-Jun C. Wong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lee-Jun C. Wong has a total of 476 co-authors. Here are the top co-authors by number of shared publications:
Jing Wang
Department of Molecular and Human Genetics Baylor College of Medicine Houston Texas
25 shared publicationsWilliam J. Craigen
Department of Molecular and Human Genetics Baylor College of Medicine Houston Texas
13 shared publicationsEric S. Schmitt
Department of Molecular and Human Genetics Baylor College of Medicine Houston Texas
12 shared publicationsVictor Wei Zhang
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
10 shared publicationsYanming Feng
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
10 shared publicationsFang-Yuan Li
Baylor College of Medicine
8 shared publications
Latest Publications
- 11 July 2020
- Published by Wiley in Human Mutation
- Vol. 41 (10) , 1783-1796
Clinical and laboratory interpretation of mitochondrial mRNA variants
Interpretation of mitochondrial protein‐encoding (mt‐mRNA) variants has been challenging due to mitochondrial characteristics that have not been addressed by American College of Medical Genetics and Genomics guidelines. We developed criteria for the interpretation of mt‐mRNA variants via literature review of reported variants, tested and refined these criteria by using our new cases, followed by interpreting 421 novel variants in our clinical database using these verified criteria. A total of 32 of 56 previously reported pathogenic (P) variants had convincing evidence for pathogenicity. These variants are either null variants, well‐known disease‐causing variants, or have robust functional data or strong phenotypic correlation with heteroplasmy levels. Based on our criteria, 65.7% (730/1,111) of variants of unknown significance (VUS) were reclassified as benign (B) or likely benign (LB), and one variant was scored as likely pathogenic (LP). Furthermore, using our criteria we classified 2, 12, and 23 as P, LP, and LB, respectively, among 421 novel variants. The remaining stayed as VUS (91.2%). Appropriate interpretation of mt‐mRNA variants is the basis for clinical diagnosis and genetic counseling. Mutation type, heteroplasmy levels in different tissues of the probands and matrilineal relatives, in silico predictions, population data, as well as functional studies are key points for pathogenicity assessments.
- 11 July 2020
- Published by Wiley in Human Mutation
- Vol. 41 (10) , 1783-1796
Clinical and laboratory interpretation of mitochondrial mRNA variants
Interpretation of mitochondrial protein‐encoding (mt‐mRNA) variants has been challenging due to mitochondrial characteristics that have not been addressed by American College of Medical Genetics and Genomics guidelines. We developed criteria for the interpretation of mt‐mRNA variants via literature review of reported variants, tested and refined these criteria by using our new cases, followed by interpreting 421 novel variants in our clinical database using these verified criteria. A total of 32 of 56 previously reported pathogenic (P) variants had convincing evidence for pathogenicity. These variants are either null variants, well‐known disease‐causing variants, or have robust functional data or strong phenotypic correlation with heteroplasmy levels. Based on our criteria, 65.7% (730/1,111) of variants of unknown significance (VUS) were reclassified as benign (B) or likely benign (LB), and one variant was scored as likely pathogenic (LP). Furthermore, using our criteria we classified 2, 12, and 23 as P, LP, and LB, respectively, among 421 novel variants. The remaining stayed as VUS (91.2%). Appropriate interpretation of mt‐mRNA variants is the basis for clinical diagnosis and genetic counseling. Mutation type, heteroplasmy levels in different tissues of the probands and matrilineal relatives, in silico predictions, population data, as well as functional studies are key points for pathogenicity assessments.
- 18 May 2020
- Published by Elsevier in Genetics in Medicine
- Vol. 22 (8) , 1420-1421
Response to Bai et al.
- 18 May 2020
- Published by Elsevier in Genetics in Medicine
- Vol. 22 (8) , 1420-1421
Response to Bai et al.
- Open Access
- 9 April 2020
- Published by Elsevier in Genetics in Medicine
- Vol. 22 (6) , 1130-1
Correction: Interpretation of mitochondrial tRNA variants
- 9 April 2020
- Published by Elsevier in Genetics in Medicine
- Vol. 22 (6) , 1130-1
Open AccessCorrection: Interpretation of mitochondrial tRNA variants
- 5 March 2020
- Published by Elsevier in Genetics in Medicine
- Vol. 22 (5) , 979-1
Correction: Interpretation of mitochondrial tRNA variants
- 5 March 2020
- Published by Elsevier in Genetics in Medicine
- Vol. 22 (5) , 979-1
Correction: Interpretation of mitochondrial tRNA variants
- Open Access
Heteroplasmy variability in individuals with biparentally inherited mitochondrial DNA
With very few exceptions, mitochondrial DNA (mtDNA) in humans is transmitted exclusively from mothers to their offspring, suggesting the presence of a strong evolutionary pressure favoring the exclusion of paternal mtDNA. We have recently shown strong evidence of paternal mtDNA transmission. In these rare situations, males exhibiting biparental mtDNA appear to be limited to transmitting just one of the mtDNA species to their offspring, while females possessing biparental mtDNA populations consistently transmit both populations to their offspring at a very similar heteroplasmy level. The precise biological and genetic factors underlying this unusual transmission event remain unclear. Here, we have examined heteroplasmy levels in various tissues among individuals with biparental inheritance. Our results indicate that individuals with biparental mtDNA have remarkable inter-tissue variability in heteroplasmy level. At the single-cell level, paternal mtDNA heteroplasmy in sperm varies dramatically, and many sperm possess only one of the two mtDNA populations originally in question. These results show a fundamental, parent-of-origin difference in how mtDNA molecules transmit and propagate. This helps explain how a single population of mtDNAs are transmitted from a father possessing two populations of mtDNA molecules, suggesting that some mtDNA populations may be favored over others when transmitted from the father.
Open AccessHeteroplasmy variability in individuals with biparentally inherited mitochondrial DNA
With very few exceptions, mitochondrial DNA (mtDNA) in humans is transmitted exclusively from mothers to their offspring, suggesting the presence of a strong evolutionary pressure favoring the exclusion of paternal mtDNA. We have recently shown strong evidence of paternal mtDNA transmission. In these rare situations, males exhibiting biparental mtDNA appear to be limited to transmitting just one of the mtDNA species to their offspring, while females possessing biparental mtDNA populations consistently transmit both populations to their offspring at a very similar heteroplasmy level. The precise biological and genetic factors underlying this unusual transmission event remain unclear. Here, we have examined heteroplasmy levels in various tissues among individuals with biparental inheritance. Our results indicate that individuals with biparental mtDNA have remarkable inter-tissue variability in heteroplasmy level. At the single-cell level, paternal mtDNA heteroplasmy in sperm varies dramatically, and many sperm possess only one of the two mtDNA populations originally in question. These results show a fundamental, parent-of-origin difference in how mtDNA molecules transmit and propagate. This helps explain how a single population of mtDNAs are transmitted from a father possessing two populations of mtDNA molecules, suggesting that some mtDNA populations may be favored over others when transmitted from the father.
- 22 January 2020
- Published by Elsevier in Genetics in Medicine
- Vol. 22 (5) , 917-926
Interpretation of mitochondrial tRNA variants
- 22 January 2020
- Published by Elsevier in Genetics in Medicine
- Vol. 22 (5) , 917-926
Interpretation of mitochondrial tRNA variants
- 1 November 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 125 (3) , 281-291
FARS2 deficiency; new cases, review of clinical, biochemical, and molecular spectra, and variants interpretation based on structural, functional, and evolutionary significance
- 1 November 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 125 (3) , 281-291
FARS2 deficiency; new cases, review of clinical, biochemical, and molecular spectra, and variants interpretation based on structural, functional, and evolutionary significance
- Open Access
- 1 September 2018
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 16, 30
Extra-muscular manifestations of TK2 deficiency
- 1 September 2018
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 16, 30
Open AccessExtra-muscular manifestations of TK2 deficiency
- 1 June 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 124 (2) , 124-130
Clinical and molecular spectrum of thymidine kinase 2-related mtDNA maintenance defect
- 1 June 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 124 (2) , 124-130
Clinical and molecular spectrum of thymidine kinase 2-related mtDNA maintenance defect
- 13 January 2018
- Published by Wiley in Human Mutation
- Vol. 39 (4) , 461-470
MPV17-related mitochondrial DNA maintenance defect: New cases and review of clinical, biochemical, and molecular aspects
Mitochondrial DNA (mtDNA) maintenance defects are a group of diseases caused by deficiency of proteins involved in mtDNA synthesis, mitochondrial nucleotide supply, or mitochondrial dynamics. One of the mtDNA maintenance proteins is MPV17 which is a mitochondrial inner membrane protein involved in importing deoxynucleotides into the mitochondria. In 2006, pathogenic variants in MPV17 were first reported to cause infantile-onset hepatocerebral mtDNA depletion syndrome and Navajo neurohepatopathy. To date, 75 individuals with MPV17-related mtDNA maintenance defect have been reported with 39 different MPV17 pathogenic variants. In this report, we present an additional 25 affected individuals with 9 novel MPV17 pathogenic variants. We summarize the clinical features of all 100 affected individuals and review the total 48 MPV17 pathogenic variants. The vast majority of affected individuals presented with an early-onset encephalohepatopathic disease characterized by hepatic and neurological manifestations, failure to thrive, lactic acidemia, and mtDNA depletion detected mainly in liver tissue. Rarely, MPV17 deficiency can cause a late-onset neuromyopathic disease characterized by myopathy and peripheral neuropathy with no or minimal liver involvement. Approximately half of the MPV17 pathogenic variants are missense. A genotype with biallelic missense variants, in particular homozygous p.R50Q, p.P98L, and p.R41Q, can carry a relatively better prognosis. This article is protected by copyright. All rights reserved
- 13 January 2018
- Published by Wiley in Human Mutation
- Vol. 39 (4) , 461-470
MPV17-related mitochondrial DNA maintenance defect: New cases and review of clinical, biochemical, and molecular aspects
Mitochondrial DNA (mtDNA) maintenance defects are a group of diseases caused by deficiency of proteins involved in mtDNA synthesis, mitochondrial nucleotide supply, or mitochondrial dynamics. One of the mtDNA maintenance proteins is MPV17 which is a mitochondrial inner membrane protein involved in importing deoxynucleotides into the mitochondria. In 2006, pathogenic variants in MPV17 were first reported to cause infantile-onset hepatocerebral mtDNA depletion syndrome and Navajo neurohepatopathy. To date, 75 individuals with MPV17-related mtDNA maintenance defect have been reported with 39 different MPV17 pathogenic variants. In this report, we present an additional 25 affected individuals with 9 novel MPV17 pathogenic variants. We summarize the clinical features of all 100 affected individuals and review the total 48 MPV17 pathogenic variants. The vast majority of affected individuals presented with an early-onset encephalohepatopathic disease characterized by hepatic and neurological manifestations, failure to thrive, lactic acidemia, and mtDNA depletion detected mainly in liver tissue. Rarely, MPV17 deficiency can cause a late-onset neuromyopathic disease characterized by myopathy and peripheral neuropathy with no or minimal liver involvement. Approximately half of the MPV17 pathogenic variants are missense. A genotype with biallelic missense variants, in particular homozygous p.R50Q, p.P98L, and p.R41Q, can carry a relatively better prognosis. This article is protected by copyright. All rights reserved